======= NR2F1 ======= == Gene Information == * **Official Symbol**: NR2F1 * **Official Name**: nuclear receptor subfamily 2 group F member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7025|7025]] * **UniProt**: [[https://www.uniprot.org/uniprot/P10589|P10589]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NR2F1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NR2F1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/132890|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a nuclear hormone receptor and transcriptional regulator. The encoded protein acts as a homodimer and binds to 5'-AGGTCA-3' repeats. Defects in this gene are a cause of Bosch-Boonstra optic atrophy syndrome (BBOAS). [provided by RefSeq, Apr 2014]. * **UniProt Summary**: Coup (chicken ovalbumin upstream promoter) transcription factor binds to the ovalbumin promoter and, in conjunction with another protein (S300-II) stimulates initiation of transcription. Binds to both direct repeats and palindromes of the 5'-AGGTCA-3' motif. Represses transcriptional activity of LHCG. {ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:11682620}. |Hormone recep| |zf-C4| |retinoic acid-responsive element binding| |nuclear receptor activity| |steroid hormone receptor activity| |steroid hormone mediated signaling pathway| |negative regulation of neuron projection development| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |transcription initiation from RNA polymerase II promoter| |negative regulation of cell projection organization| |cellular response to steroid hormone stimulus| |DNA-templated transcription, initiation| |negative regulation of neuron differentiation| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |transcription coactivator activity| |negative regulation of neurogenesis| |negative regulation of nervous system development| |RNA polymerase II regulatory region sequence-specific DNA binding| |response to steroid hormone| |negative regulation of cell development| |sequence-specific DNA binding| |transcription by RNA polymerase II| |regulation of neuron projection development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of neuron differentiation| |DNA-binding transcription factor activity| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of neurogenesis| |zinc ion binding| |response to lipid| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |neurogenesis| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp482|Fas-L 44ng/ml R08 exp482]]|-2.06| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.7| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8108 * **Expression level (log2 read counts)**: -0.9 {{:chemogenomics:nalm6 dist.png?nolink |}}